An Investigator-Sponsored Randomized Phase III Trial of Maintenance with Selinexor/ Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer
EUDRA-CT number: 2017-000607-25
Study sites:
- UZ Leuven, Leuven
- Jan Yperman ziekenhuis, Ieper
- AZ Turnhout, Turnhout
- CHU Ambroise Paré, Mons
